XiaoyuNovember 07, 2018
Tag: china , Insulin , national essential drugs
New Edition of China’s National Essential Drugs List Released:
Types of Insulin and Oral Hypoglycemic Drug Increased by 150%, with Varieties being Newer and More Complete!
National Essential Drugs List
--2018 Edition--
Type |
2012 edition |
2018 edition |
|||
Variety name |
Dosage form, specification |
Variety name |
Dosage form, specification |
||
Insulin |
Insulin |
Animal-sourced insulin injection (short-acting, intermediate-acting, long-acting, and premixed): 400 units Recombinant human insulin injection (short-acting, intermediate-acting, and premixed 30R): 300 units, 400 units |
Insulin |
Animal-sourced insulin injection (short-acting, intermediate-acting, long-acting, and premixed): 300 units, 400 units Recombinant human insulin injection (short-acting, intermediate-acting, and premixed 30R): 300 units, 400 units |
|
|
|
Insulin Glargine |
Injection: 3ml:300 units (prefilled), 3ml:300 units (refill) |
||
Non-insulin secretagogue |
Thiazolidinedione (glitazone) |
|
|
Pioglitazone |
Tablet: 15mg, 30mg Capsule: 15mg, 30mg |
Biguanide |
Metformin |
Tablet, enteric-coated (tablet, capsule), sustained-release tablet: 0.25g, 0.5g Capsule: 0.25g |
Metformin |
Tablet, enteric-coated (tablet, capsule), sustained-release tablet: 0.25g, 0.5g Capsule: 0.25g Sustained-release capsule: 0.25g |
|
SGLT-2 inhibitor |
|
|
Dapagliflozin |
Tablet: 5mg, 10mg |
|
Alpha-glucosidase inhibitor |
Acarbose |
Tablet, capsule: 50mg |
Acarbose |
Tablet, capsule: 50mg |
|
Type |
2012 edition |
2018 edition |
|||
Variety name |
Dosage form, specification |
Variety name |
Dosage form, specification |
||
Incretin |
GLP-1 receptor agonist |
|
|
Liraglutide |
Injection: 3ml:18mg |
DPP-4 inhibitor |
|
|
Sitagliptin |
Tablet: 25mg, 50mg, 100mg |
|
|
|
Linagliptin |
Tablet: 5mg |
||
Insulin secretagogue |
Sulfonylurea
|
Glibenclamide |
Tablet: 2.5mg |
Glibenclamide |
Tablet: 2.5mg |
Glipizide |
Tablet, capsule: 5mg |
Glipizide |
Tablet, capsule: 5mg |
||
Glimepiride |
Tablet: 1mg, 2mg |
Glimepiride |
Tablet: 1mg, 2mg |
||
|
|
Gliquidone |
Tablet: 30mg |
||
|
|
Gliclazide |
Tablet (II): 80mg |
||
Non-sulfonylurea (glinide) |
|
|
Repaglinide |
Tablet: 0.5mg, 1mg, 2mg |
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: